GEN vs. NTES, ADSK, SNOW, NET, SQ, XYZ, DDOG, HUBS, RBLX, and VEEV
Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include NetEase (NTES), Autodesk (ADSK), Snowflake (SNOW), Cloudflare (NET), Block (SQ), Block (XYZ), Datadog (DDOG), HubSpot (HUBS), Roblox (RBLX), and Veeva Systems (VEEV). These companies are all part of the "prepackaged software" industry.
Genesis Healthcare vs.
NetEase (NASDAQ:NTES) and Genesis Healthcare (NYSE:GEN) are both large-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.
11.1% of NetEase shares are owned by institutional investors. Comparatively, 82.1% of Genesis Healthcare shares are owned by institutional investors. 54.7% of NetEase shares are owned by insiders. Comparatively, 3.3% of Genesis Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
NetEase has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Genesis Healthcare has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.
NetEase has higher revenue and earnings than Genesis Healthcare. NetEase is trading at a lower price-to-earnings ratio than Genesis Healthcare, indicating that it is currently the more affordable of the two stocks.
NetEase received 205 more outperform votes than Genesis Healthcare when rated by MarketBeat users. Likewise, 69.18% of users gave NetEase an outperform vote while only 65.43% of users gave Genesis Healthcare an outperform vote.
NetEase pays an annual dividend of $1.73 per share and has a dividend yield of 1.7%. Genesis Healthcare pays an annual dividend of $0.50 per share and has a dividend yield of 1.8%. NetEase pays out 29.2% of its earnings in the form of a dividend. Genesis Healthcare pays out 55.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
NetEase currently has a consensus price target of $111.43, suggesting a potential upside of 7.95%. Genesis Healthcare has a consensus price target of $31.50, suggesting a potential upside of 16.45%. Given Genesis Healthcare's higher possible upside, analysts clearly believe Genesis Healthcare is more favorable than NetEase.
NetEase has a net margin of 26.02% compared to Genesis Healthcare's net margin of 17.83%. Genesis Healthcare's return on equity of 155.48% beat NetEase's return on equity.
In the previous week, NetEase had 28 more articles in the media than Genesis Healthcare. MarketBeat recorded 29 mentions for NetEase and 1 mentions for Genesis Healthcare. NetEase's average media sentiment score of 0.69 beat Genesis Healthcare's score of 0.00 indicating that NetEase is being referred to more favorably in the media.
Summary
NetEase beats Genesis Healthcare on 13 of the 20 factors compared between the two stocks.
Get Genesis Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genesis Healthcare Competitors List
Related Companies and Tools
This page (NYSE:GEN) was last updated on 2/22/2025 by MarketBeat.com Staff
